Regeneron Pharmaceuticals (REGN)

Income Before Tax

$1.53B

Quarterly · Period ending: · USD

REGN logo

REGN Income Before Tax

Latest reported$1.53B
REGN Quarterly Pre-Tax Income ($0.00 → $1.53B)
High-resolution chart · PNG

REGN income before tax history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Income Before Tax — Quarterly (USD)
Period endingIncome Before Tax (USD)
1,527,800,000
831,200,000
1,043,700,000
1,763,300,000
1,518,700,000
905,000,000
958,100,000
1,493,000,000
1,628,100,000
700,700,000
1,147,600,000
1,110,800,000
1,082,900,000
858,000,000
1,324,700,000
1,509,800,000
963,200,000
1,061,100,000
2,503,400,000
1,816,600,000
3,752,800,000
1,253,000,000
1,224,600,000
998,300,000
918,900,000
668,600,000
889,800,000
768,500,000
224,700,000
546,100,000
676,200,000
635,861,000
656,074,000
585,398,000
554,767,000
565,605,000
525,850,000
432,289,000
341,527,000
365,881,000
292,256,000
330,151,000
227,289,000
393,289,000
327,996,000
276,523,000
221,287,000
176,078,000
203,119,000
175,263,000
198,153,000
225,684,000
147,692,000
141,831,000
134,559,000
191,468,000
76,743,000
11,651,000
-54,058,000
-61,803,000
-63,368,000
-43,663,000
-14,597,000
-31,641,000
-23,132,000
-30,304,000
-40,611,000
-1,015,000
-14,938,000
-17,481,000
-32,246,000
-18,036,000
-15,785,000
-8,607,000
-10,061,000
-32,827,000
-23,763,000
-26,906,000
-103,150,000
-27,410,000
-25,706,000
0
222,181,000
-31,641,000
-23,988,000
-1,110,000
3,974,000
-8,062,000
-11,538,000
67,668,000
-16,271,000
-24,418,000
-25,831,000
-27,171,000
-32,900,000
-29,799,000
-27,396,000
-22,423,000
-25,851,000
-19,891,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.